News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
590,279 Results
Type
Article (47099)
Company Profile (168)
Press Release (543012)
Multimedia
Podcasts (63)
Webinars (12)
Section
Business (164252)
Career Advice (2581)
Deals (29841)
Drug Delivery (105)
Drug Development (75839)
Employer Resources (155)
FDA (13918)
Job Trends (13214)
News (289385)
Policy (28151)
Tag
Academia (2611)
Academic (1)
Accelerated approval (5)
Adcomms (28)
Allergies (81)
Alliances (42263)
ALS (94)
Alzheimer's disease (1425)
Antibody-drug conjugate (ADC) (144)
Approvals (13905)
Artificial intelligence (261)
Autoimmune disease (27)
Automation (16)
Bankruptcy (324)
Best Places to Work (10468)
BIOSECURE Act (20)
Biosimilars (94)
Biotechnology (138)
Bladder cancer (81)
Brain cancer (27)
Breast cancer (270)
Cancer (2243)
Cardiovascular disease (189)
Career advice (2161)
Career pathing (33)
CAR-T (160)
Cell therapy (442)
Cervical cancer (17)
Clinical research (61691)
Collaboration (811)
Company closure (1)
Compensation (329)
Complete response letters (24)
COVID-19 (2557)
CRISPR (44)
C-suite (258)
Cystic fibrosis (93)
Data (2173)
Decentralized trials (2)
Denatured (11)
Depression (53)
Diabetes (266)
Diagnostics (5872)
Digital health (14)
Diversity (5)
Diversity, equity & inclusion (41)
Drug discovery (120)
Drug pricing (96)
Drug shortages (23)
Duchenne muscular dystrophy (92)
Earnings (58538)
Editorial (40)
Employer branding (20)
Employer resources (139)
Events (86012)
Executive appointments (738)
FDA (15099)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (725)
Gene editing (106)
Generative AI (20)
Gene therapy (328)
GLP-1 (725)
Government (4210)
Grass and pollen (5)
Guidances (65)
Healthcare (16452)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (135)
Indications (27)
Infectious disease (2705)
Inflammatory bowel disease (139)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (94)
Interviews (530)
IPO (13483)
IRA (43)
Job creations (3137)
Job search strategy (1783)
Kidney cancer (11)
Labor market (29)
Layoffs (465)
Leadership (23)
Legal (6120)
Liver cancer (76)
Lung cancer (328)
Lymphoma (151)
Machine learning (7)
Management (54)
Manufacturing (296)
MASH (74)
Medical device (10740)
Medtech (10744)
Mergers & acquisitions (16858)
Metabolic disorders (698)
Multiple sclerosis (80)
NASH (23)
Neurodegenerative disease (104)
Neuropsychiatric disorders (32)
Neuroscience (1992)
NextGen: Class of 2025 (5815)
Non-profit (4061)
Now hiring (34)
Obesity (363)
Opinion (249)
Ovarian cancer (74)
Pain (95)
Pancreatic cancer (81)
Parkinson's disease (150)
Partnered (20)
Patents (227)
Patient recruitment (111)
Peanut (44)
People (54096)
Pharmaceutical (31)
Pharmacy benefit managers (10)
Phase I (19232)
Phase II (27186)
Phase III (20482)
Pipeline (1196)
Policy (145)
Postmarket research (2358)
Preclinical (7974)
Press Release (69)
Prostate cancer (102)
Psychedelics (38)
Radiopharmaceuticals (235)
Rare diseases (393)
Real estate (5004)
Recruiting (65)
Regulatory (19878)
Reports (30)
Research institute (2230)
Resumes & cover letters (383)
Rett syndrome (5)
RNA editing (4)
RSV (42)
Schizophrenia (78)
Series A (130)
Series B (85)
Service/supplier (9)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (149)
Sponsored (29)
Startups (3266)
State (2)
Stomach cancer (15)
Supply chain (64)
Tariffs (38)
The Weekly (51)
Vaccines (695)
Venture capitalists (42)
Weight loss (247)
Women's health (27)
Worklife (19)
Date
Today (119)
Last 7 days (827)
Last 30 days (2410)
Last 365 days (30402)
2025 (9986)
2024 (32576)
2023 (36252)
2022 (46925)
2021 (50434)
2020 (48452)
2019 (41461)
2018 (31529)
2017 (29013)
2016 (27716)
2015 (32200)
2014 (26133)
2013 (22320)
2012 (21469)
2011 (22435)
2010 (20016)
Location
Africa (810)
Alabama (50)
Alaska (5)
Arizona (156)
Arkansas (11)
Asia (36768)
Australia (7407)
California (5473)
Canada (1878)
China (511)
Colorado (227)
Connecticut (241)
Delaware (143)
Europe (82479)
Florida (842)
Georgia (172)
Idaho (51)
Illinois (496)
India (25)
Indiana (280)
Iowa (8)
Japan (160)
Kansas (93)
Kentucky (20)
Louisiana (9)
Maine (49)
Maryland (832)
Massachusetts (4038)
Michigan (200)
Minnesota (335)
Mississippi (1)
Missouri (75)
Montana (25)
Nebraska (24)
Nevada (57)
New Hampshire (65)
New Jersey (1582)
New Mexico (25)
New York (1588)
North Carolina (890)
North Dakota (7)
Northern California (2367)
Ohio (175)
Oklahoma (10)
Oregon (28)
Pennsylvania (1191)
Puerto Rico (12)
Rhode Island (30)
South America (1104)
South Carolina (19)
South Dakota (1)
Southern California (2114)
Tennessee (87)
Texas (827)
United States (20680)
Utah (173)
Virginia (137)
Washington D.C. (54)
Washington State (530)
West Virginia (3)
Wisconsin (47)
590,279 Results for "pharmacyte biotech formerly known as nuvilex".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
PharmaCyte Biotech, Inc. today announced a $7 million investment in MyMD Pharmaceuticals, Inc.
May 21, 2024
·
4 min read
Tariffs
Biotech’s ‘Nauseating Roller Coaster’ Repels Investors
Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty sent fresh shockwaves through an already fragile market.
April 23, 2025
·
5 min read
·
Ana Mulero
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Business
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.
PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) (“Femasys”), a biomedical company focused on meeting significant unmet needs for women worldwide.
November 15, 2023
·
4 min read
Business
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
Femasys Inc. today announced a strategic upfront investment of $6.85 million by public biotech company, PharmaCyte Biotech, Inc. (Nasdaq: PMCB) and other healthcare investors.
November 15, 2023
·
6 min read
Regulatory
Biotech Leaders Implore Sen. Cassidy To Step Up in Wake of FDA Cuts
Biotech companies are already seeing regulatory delays and plenty of uncertainty after around 3,500 FDA employees were cut by the Trump administration.
April 10, 2025
·
3 min read
·
Annalee Armstrong
China
Amid Trade Tensions, Commission Warns China is ‘Dangerously Close’ to Overtaking US Biotech
The National Security Commission on Emerging Biotechnology recommends at least a $15 billion investment into biotech over the next five years.
April 9, 2025
·
2 min read
·
Tristan Manalac
Leadership
Biotech CEO Sisterhood Fills ‘Unmet Need’ for Fellowship Among Women Leaders
At the J.P. Morgan Healthcare Conference, the Biotech CEO Sisterhood assembled in Union Square to showcase the large group of women and allies in biopharma as their authentic selves.
February 5, 2025
·
4 min read
·
Annalee Armstrong
Government
Lawmakers Seek to Boost US Biotech Sector, Keep China’s Growth in Check
According to analysts at Jefferies, legislation such as the newly proposed bills that aim to streamline regulatory processes would be a positive for the biotech industry.
April 11, 2025
·
2 min read
·
Tristan Manalac
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
1 of 59,028
Next
